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Abstract
Sex chromosome dosage compensation in Drosophila provides a model for understanding how chromatin organization can
modulate coordinate gene regulation. Male Drosophila increase the transcript levels of genes on the single male X
approximately two-fold to equal the gene expression in females, which have two X-chromosomes. Dosage compensation is
mediated by the Male-Specific Lethal (MSL) histone acetyltransferase complex. Five core components of the MSL complex
were identified by genetic screens for genes that are specifically required for male viability and are dispensable for females.
However, because dosage compensation must interface with the general transcriptional machinery, it is likely that
identifying additional regulators that are not strictly male-specific will be key to understanding the process at a mechanistic
level. Such regulators would not have been recovered from previous male-specific lethal screening strategies. Therefore, we
have performed a cell culture-based, genome-wide RNAi screen to search for factors required for MSL targeting or function.
Here we focus on the discovery of proteins that function to promote MSL complex recruitment to ‘‘chromatin entry sites,’’
which are proposed to be the initial sites of MSL targeting. We find that components of the NSL (Non-specific lethal)
complex, and a previously unstudied zinc-finger protein, facilitate MSL targeting and display a striking enrichment at MSL
entry sites. Identification of these factors provides new insight into how MSL complex establishes the specialized
hyperactive chromatin required for dosage compensation in Drosophila.
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Introduction
X-chromosome dosage compensation in male Drosophila pro-
vides a model for understanding how a large number of diversely
regulated genes along the length of a single chromosome can be
targeted for coordinate regulation. In Drosophila, the transcript
levels of genes along the length of the single male X-chromosome
are upregulated approximately two-fold, a process mediated by the
MSL (Male-specific lethal) histone acetyltransferase complex [1].
A model, initially based on genetic observations [2], posits that the
MSL complex binds the X-chromosome in a two-step process.
First, high levels of the MSL complex accumulate at approxi-
mately 150–300 ‘‘chromatin entry sites’’ (CES) containing GA-
rich MRE (MSL Recognition Element) sequences that are ,two-
fold enriched on the male X [3][4]. Second, a sequence-
independent spreading occurs in which the MSL complex
associates with the bodies of active X-linked genes via general
features associated with transcription, including H3K36me3 [5].
MSL complex increases transcript levels of its target genes by
increasing the density of RNA Polymerase II (RNAP II) over
transcription units, likely via MSL-dependent H4K16 acetylation
[6].
While significant progress has been made towards understand-
ing how MSL complex is targeted and functions, much remains to
be understood. For example, since MREs are less than two-fold
enriched on the X-chromosome [3] and the core MSL complex
does not appear to have sequence-specific DNA binding activity
[7], it is likely that additional factors are involved in the key
process of CES recognition.
Seminal genetic screens identified five core components of the
MSL complex by isolating genes that were specifically required for
male viability [8][9]. However, these approaches would not
recover a potentially key class of regulators that might be required
for viability in both sexes, and act in dosage compensation by
providing an interface with the core transcriptional machinery. In
fact, based on experiments from budding yeast [10][11] the
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potential regulator of MSL complex association with active genes
[5][12]. SET2 contributes to targeting of the MSL complex to the
bodies of active genes [5][12], but it is likely that other factors also
participate. Furthermore, there are no candidates for direct
binding to the MRE sequence, which is proposed to be a key
first step in MSL targeting.
Therefore, we designed a cell-based reporter system that
specifically monitors MSL function at chromatin entry sites, and
conducted a genome-wide RNAi screen to identify genes required
to regulate this reporter. We identified the NSL [13][14] and PAF
[15][16] general transcriptional regulators, as well as a previously
unstudied zinc finger protein, CG1832, that emerges as a strong
candidate to function as the previously unknown link between
MSL complex and MRE sequences within chromatin entry sites.
Results
A genome-wide RNAi screen identifies genes that
regulate an MSL-dependent reporter in male SL2 cells
In order to identify genes that regulate MSL complex
recruitment or function, we performed a genome-wide RNAi
screen using an MSL-dependent cell-based reporter system for
which we previously reported functionality [3] (Figure 1A). This
reporter system includes the following three elements: 1) promoter
of roX2 gene (370 bp); 2) Firefly luciferase reporter gene; 3) MSL
complex binding site for roX2 (DNase I Hypersensitivity Site:
280 bp). The system is based on a similar one that functions as a
male-specific MSL-dependent reporter in vivo [17]. A genome-
wide RNAi library generated by the Drosophila RNAi Screening
Center (DRSC) that contains approximately 21,000 dsRNAs was
screened in duplicate (www.flyrnai.org). To eliminate off-target
effects, secondary screens were conducted using a set of validation
RNAi constructs in addition to rescreening the original constructs.
In addition to direct regulators of MSL complex recruitment or
function, several additional types of genes could be identified by
our RNAi screen. Therefore, we used the following steps to
identify potential direct activators of MSL complex targeting: 1)
To reduce the number of non-specific regulators of luciferase gene
transcription and protein stability that were identified, we
calculated the ratio of activity from our MSL-dependent Firefly
luciferase reporter to a heterologous Renilla luciferase reporter. 2)
We used multiple MSL-dependent reporters to further narrow the
list of genes to those that function independently of the roX2
promoter and specific CES used in the genome-wide screen; 3) We
then used known functional information about the genes to narrow
the list to those that have potential direct activating roles; 4) We
determined whether new proteins affect MSL complex recruit-
ment at endogenous sites without altering transcription of MSL
complex components; 5) We performed genome-wide localization
analysis to determine whether new proteins are enriched at CES
loci.
As briefly described above, we first normalized the MSL-
dependent Firefly luciferase reporter activity to an MSL-indepen-
dent reporter including the Renilla luciferase gene that can be
independently assayed using a different substrate. This dual
Firefly/Renilla approach also controls for technical variation in
transfection efficiencies among wells and differences in cell
number caused by altered viability after RNAi treatments. We
used a Renilla construct that was regulated by an Actin promoter
as previously described [18]. Therefore, by calculating the ratio of
Firefly/Renilla luciferase activity, RNAi conditions that specifi-
cally alter the MSL-dependent reporter but not the Actin-Renilla
construct could be identified.
To conduct the RNAi screen, sixty-two screening plates
containing approximately 21,000 dsRNAs arrayed in individual
wells of a 384-well plate were assayed in duplicate. Each plate
contained two positive control (msl2 RNAi) and two negative
control (GFP RNAi) constructs, that were previously validated.
After confirming that at least a 5-fold dynamic range was observed
in the expected activity of positive and negative controls on each
plate, the Firefly/Renilla ratios of the two plates were averaged
and screening hits were identified relative to the median Firefly/
Renilla ratio for each plate (See Methods). We also conducted the
same computational analysis for the Renilla values and removed
hits in which the Renilla activity was dramatically altered by the
RNAi treatment (See Methods).
Our screening approach identified 322 RNAi constructs that
altered MSL-dependent reporter activity (Table S1). Importantly,
we found all known components of the MSL complex in an
unbiased way, validating our screen (Figure 1B). We identified 254
RNAi constructs that reduced MSL-dependent reporter activity
and 68 RNAi constructs that increased reporter activity. Gene
Ontology analysis revealed several functional categories that were
enriched including the following: protein synthesis, cell cycle
control, and transcriptional regulation (p,0.05) (Table 1). Similar
analysis of publically available data sets from other RNAi screens
performed using the same library indicated that the transcriptional
regulation Gene Ontology category was not enriched in any other
publically available screens. In contrast, the protein synthesis
category and cell cycle control categories were commonly enriched
in the majority of screens conducted with this RNAi library.
Next, candidate genes were chosen for further analysis and
validation with additional RNAi constructs. Three classes of genes
were removed from the original list of candidates: 1) Ribosomal
protein genes that are identified by many RNAi screens (41 genes);
2) Genes with a large number of predicted RNAi off targets using
17 bp as an overlap cutoff [19] (19 genes) 3) RNAi amplicons that
did not target a specific gene and/or target multiple predicted
genes (21 amplicons). We rescreened the 241 remaining candidates
using both original and validation RNAi constructs with the
original screening system and two additional MSL-dependent
reporters that we previously validated [3]. These additional MSL-
dependent reporters had a different promoter or CES compared
Author Summary
Gene regulation is essential to all living things. For
example, levels of gene expression in individual cells must
be fine-tuned during development and in response to
changing environmental conditions. Genes are regulated
by DNA binding proteins and by factors that influence
DNA packaging into chromatin. The MSL complex in
Drosophila melanogaster is a chromatin-modifying com-
plex that specifically regulates a large number of genes.
The MSL complex targets active genes on the single male
X chromosome to upregulate their output to match both
female X chromosomes. How the MSL complex specifically
targets the X chromosome and upregulates active genes is
only partially understood. In order to increase our
understanding of gene regulation at a mechanistic level,
we performed a genome-wide genetic screen in male cells
to identify factors that facilitate MSL targeting and
function. Our results identify two chromatin-associated
protein complexes and a new candidate DNA binding
protein as key factors in MSL–based regulation. We also
provide an extensive list of additional candidate genes to
be examined in future studies.
Factors Targeting Drosophila Dosage Compensation
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described (Figure 1A). In this way, we identified 72 genes that were
validated with an additional RNAi construct and regulated all
three MSL-dependent reporters (Table S2). We do not wish to
over-interpret any negative results; however, we did not identify
the genes encoding HP1, SU(VAR)3–7, or ISWI. These each have
a mutant phenotype that differentially affects the polytene X
chromosome [20][21], but may not affect MSL function. Likewise,
we did not identify JIL-1, SCF, NUP153, or Megator, all
previously implicated in MSL interaction [22][23][13].
To narrow our list of candidate genes, we classified genes into
categories based on their activity in our assay and previously
Figure 1. An RNAi screening system in Drosophila SL2 cells to identify regulators of MSL complex recruitment and function. A)
Schematic of the MSL-dependent reporter system for SL2 cell-based genome-wide RNAi screening. The system includes the following three elements:
1) promoter of roX2 gene (370 bps); 2) Firefly luciferase reporter gene; 3) roX2 DHS (DNase I Hypersensitivity Site: 280 bp). Two additional constructs
were used for secondary screening in which the promoter or CES were altered. The alternative promoter is that of the CG2690 gene and the
alternative CES is the minimal 150 bp fragment of CES5C2 that were previously described [3]. B) Ratio of the Firefly luciferase activity to Renilla
luciferase activity for MSL complex component RNAi treatments identified from the genome-wide screen. Data shown are the average and standard
deviation of two replicates from the genome-wide screening plates. Control RNAi treatment targeted the GFP gene that is not present in SL2 cells.
doi:10.1371/journal.pgen.1002830.g001
Factors Targeting Drosophila Dosage Compensation
PLoS Genetics | www.plosgenetics.org 3 July 2012 | Volume 8 | Issue 7 | e1002830determined functional information about the gene products as
follows (Table S2): 1) Class 1 (18 genes): General transcrip-
tional regulators that activate our reporter; 2) Class 2 (6 genes):
Proteins that have potential sequence-specific DNA binding
activity and activate our reporter; 3) Class 3 (7 genes): General
transcriptional regulators that repress our reporter; 4) Class 4 (3
genes): Proteins that have potential sequence-specific DNA
binding activity and repress our reporter; 5) Class 5 (7 genes):
Proteins that regulate RNA metabolism (e.g. splicing, non-sense
mediated decay); 6) Class 6 (26 genes): Proteins that are
previously unstudied and/or have functions unrelated to tran-
scription or RNA metabolism. The remaining genes are known
MSL complex components. Members of each of these classes
could directly modulate MSL recruitment or activity or indirectly
effect MSL complex by altering complex levels.
Due to the large number of genes identified, we focused on
potential direct regulators of MSL complex recruitment or
function that had known roles in transcriptional regulation or
potential DNA binding domains (Classes 1–4). This analysis
identified 34 potential transcriptional regulators. We validated the
activity of these candidate genes using our MSL-dependent
reporter assay in a more accurate 96-well format (Figure 2).
Overall, we identified 24 activators (Classes 1 and 2) and 9
repressors (Classes 3 and 4) with known or predicted roles in
transcriptional regulation.
In addition to identifying all core components of MSL complex
as activators of our reporter system (Figure 1B), we identified a
known repressor of MSL function, NURF301, which we
previously determined represses roX gene transcription in vivo
[24] (Table S2). Also, NURF301 is known to associate with the
roX1 CES [24]. Therefore, our RNAi screening strategy identified
all MSL complex components and a known direct repressor of
MSL-dependent transcription, validating our ability to identify
activators and repressors with direct functions.
Selection of NSL complex, PAF complex, and CG1832 as
candidate direct regulators of MSL targeting or function
The transcription of MSL complex components could be
modulated and thus indirectly affect its function. Therefore, we
selected candidates and examined whether they function directly
to recruit MSL complex to CES loci using several approaches: 1)
Determine whether RNAi against candidate genes affects recruit-
ment of MSL complex to endogenous CES; 2) Define whether
RNAi knockdown of candidates alters transcription of MSL
complex components; 3) Examine the recruitment of candidate
proteins to CES loci. We hypothesized that direct regulators of
MSL complex recruitment will be recruited to CES loci and alter
MSL complex recruitment but not transcription of MSL complex
components. Using these approaches, we examined the function of
three factors: 1) the NSL complex; 2) the PAF complex; and 3)
CG1832.
We selected NSL complex for further study because six of its
components (NSL1,NSL3, CG1135, z4,Chro, and MBD-R2) were
identified in our screen and NSL and MSL complexes share the
MOF catalytic component. NSL1 is one of the structural
components of NSL complex that directly contacts MOF using a
similar protein-protein interaction surface as MSL1 [25]. Although
this biochemical relationship would predict that NSL complex
would compete with MSL complex for the MOF subunit, NSL
complex was identified as an activator of our MSL-dependent
reporter. Therefore, we further characterized the relationship
between the two complexes to determine whether NSL complex
functions positively during MSL complex recruitment.
We also examined the PAF transcription complex that
associates with RNAP II across gene bodies to promote
transcription elongation [26][16]. Again, we identified multiple
subunits of this complex in our screen, making the PAF complex a
strong candidate. The PAF complex has been implicated in
facilitating H2B ubquitylation catalyzed by the S. cerevisiae SAGA
complex component Ubp8 [27][28]. Intriguingly, recent work has
identified a new activity for the MSL2 protein as an E3 ligase that
targets H2BK34 for ubiquitylation (H2BK31 in Drosophila) [29].
Therefore, it is possible that the PAF complex facilitates the H2B
ubiquitin ligase activity of MSL2. Also, MSL complex associates
with gene bodies of active genes like the PAF complex [30][31].
The previously-unstudied CG1832 zinc finger protein was
chosen for further study because it was identified three indepen-
dent times using different double-stranded RNA constructs and
exhibits a very strong reporter activation phenotype. Furthermore,
unlike other potential DNA binding proteins, CG1832 RNAi does
not decrease cell viability significantly and was not identified by
other RNAi screens. Similarly, loss of MSL complex components
does not significantly alter cell viability although it causes male-
specific lethality in flies. The CG1832 protein has a glutamine rich
N-terminus and a seven zinc finger domain at its C-terminus.
Because each finger is likely to recognize three bases [32], CG1832
is a candidate for recognition of a 21-mer sequence such as the
MRE element. CG1832 is highly conserved among insect species
and orthologs are present in other species such as mouse (znf80)
and human (znf429). Furthermore, CG1832 is maternally loaded
into the early embryo and ubiquitiously expressed (FlyAtlas) and
therefore it could potentially target MSL complex early in
development. In addition, CG1832 is likely to be an essential
gene because P-element insertions at its 59 end are lethal in both
sexes (data not shown). Therefore, CG1832 would not have been
identified by the seminal male-specific lethal screens in vivo.
CG1832 and NSL complex modulate MSL complex
recruitment to endogenous CES loci in vivo
To determine whether candidate genes are needed for MSL
complex recruitment to endogenous CES loci, we used chromatin
immunoprecipitation (ChIP) of the MSL2 core component in male
SL2 cells. We found that both NSL1 and CG1832 RNAi
knockdowns significantly reduce MSL2 recruitment to several
CES loci in vivo (Figure 3A). Next, we conducted ChIP on the
H4K16ac histone modification to examine the roles of NSL1 and
CG1832 in depositing this key modulator of dosage compensation.
In parallel with the effect on MSL2 recruitment, both NSL1 and
CG1832 RNAi caused reduced H4K16ac at several CES loci. In
contrast, PAF RNAi treatment did not alter MSL complex
recruitment and therefore it is likely that PAF functions to alter
Table 1. Gene ontology categories that were enriched in the
genome-wide RNAi screen.
Functional Category P-value
Protein biosynthesis 1.01E-22
Cell cycle 4.24E-07
Cell cycle control 1.18E-06
mRNA transcription 4.03E-06
Protein metabolism and modification 3.38E-05
Nucleoside, nucleotide and nucleic acid metabolism 1.03E-04
mRNA transcription regulation 2.99E-02
doi:10.1371/journal.pgen.1002830.t001
Factors Targeting Drosophila Dosage Compensation
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(Figure 3A).
To examine whether NSL1 and CG1832 RNAi treatments
disrupt MSL complex recruitment due to regulation of MSL
complex component mRNA levels, we assayed these by qRT-PCR
(Figure S1). roX1 is not expressed at significant levels in SL2 cells
[33]. We noted effects on roX2 RNA levels as expected because
roX2 is activated by MSL complex, but little effect on the mRNA
Figure 2. Candidate regulators of MSL complex identified from the genome-wide RNAi screen. The Firefly/Renilla luciferase activity ratio
and its standard deviation was determined based on quadruplicate reactions in 96-well plate format after RNAi treatment targeting the following
classes of candidate genes: A) Class 1: NSL complex, PAF complex and other general transcriptional regulators; B) Class 2: Activators with potential
specific DNA binding activity like CG1832.
doi:10.1371/journal.pgen.1002830.g002
Factors Targeting Drosophila Dosage Compensation
PLoS Genetics | www.plosgenetics.org 5 July 2012 | Volume 8 | Issue 7 | e1002830Figure 3. NSL1 and CG1832 contribute to MSL complex recruitment. A) Chromatin immunoprecipitation was conducted using an antibody
specific for the MSL2 protein before and after RNAi treatment targeting the paf1, nsl1 and CG1832 genes. Four CES loci and the 39 ends of three
previously characterized MSL complex target genes were assayed [3,5]. Data shown are the average and standard deviation of at least two replicates.
Normalization was conducted both to input DNA material and to the non-transcribed CG15570 gene as an internal control as previously described
[42]. B) Chromatin immunoprecipitation was conducted as described for (A) but an antibody targeting the H4K16ac histone modification (Millipore)
Factors Targeting Drosophila Dosage Compensation
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CG1832 RNAi treatments do not affect mRNA splicing of MLE
as reported for the Znf72D zinc finger protein (data not shown)
[34]. MLE splicing was quantified using splice-site specific primers
that were previously validated [34]. Because improper targeting of
MSL complex reduces complex stability [35], precise measure-
ments of MSL protein levels do not address the point at which
NSL1 or CG1832 acts to promote MSL complex activity. Instead,
we tested the hypothesis that these proteins promote MSL
recruitment by assessing their own localization to CES loci.
Genome-wide occupancy of NSL components and
CG1832 support a direct role in MSL targeting
To define NSL complex and CG1832 localization on chroma-
tin, we analyzed the genome-wide occupancy of both factors.
Genome-wide localization data were available for the Chromator/
Chriz and MBD-R2 components of the NSL complex (www.
modENCODE.org). Therefore, we analyzed the enrichment of
these proteins at CES loci compared with other sites that contain
MRE sequences. Results indicate that there is a broad enrichment
of NSL complex components within a 10 kb region surrounding
CES compared to additional genomic loci on the X and
autosomes that contain MREs (Figure 4A), consistent with a local
or regional function.
To assess the genome-wide occupancy of CG1832, we
generated a polyclonal antibody that targets the N-terminus of
the protein (see Methods). We validated that the CG1832 antibody
recognizes a protein of the predicted size and its RNAi knockdown
strongly reduces its protein and mRNA levels and association with
chromatin (Figures S1, S2, S3). CG1832 is expressed in both males
and females and binds to polytene chromosomes in both sexes,
consistent with it having a general, essential function in addition to
its potential role in facilitation of MSL targeting (Figures S2, S4).
We performed ChIP-seq analysis on the CG1832 protein in male
SL2 cells and mapped 2,695 CG1832 sites on the X and 10,009 on
autosomes using inclusive statistical criteria for defining binding
sites (see Methods). Overall, MREs on the X chromosome are
approximately 1.5-fold more likely to be occupied by CG1832
than MREs on autosomes (49.7% on X: 1832/3683; 32.5% on
autosomes: 3787/11619). Although CG1832 occupancy is not X-
specific, it is highly enriched at CES loci. In fact, 98.5% (135/137)
of the genetically defined CES that contain MRE sequences [3]
have a CG1832 binding site. Also, 92.5% (446/484) of all MSL
complex binding sites that contain an MRE also have a CG1832
binding site. This expanded set would include likely CES not
characterized previously. Most compelling, CG1832 occupancy at
MREs is strongly enriched at CES compared with locations on the
X and autosomes that contain MRE sequences but fail to recruit
MSL complex, as visualized by heat maps for enrichment at
various classes of MREs (Figure 4B). Comparison of ChIP-seq and
ChIP-chip profiles of CG1832, MBD-R2, and Chromator show
similar localization to 59 ends of active genes, with CG1832 more
focused at CES (Figure 4C). The precise pattern of enrichment
over MREs makes CG1832 a strong candidate to directly
recognize these sequences. These results demonstrate that our
genetic screen has identified at least two new regulators of MSL
complex recruitment that are implicated in functioning directly at
chromatin entry sites.
Discussion
Using a novel cell-based RNAi screening approach, we have
identified new candidate regulators of MSL complex function. The
screen took advantage of the ,five fold regulation of a roX2-
luciferase reporter construct by MSL complex, rather than relying
on a direct assay of dosage compensation (,two fold) or on more
laborious assays for MSL occupancy. Many of the regulators that
we have identified are likely to have additional functions in both
male and female flies and therefore could not have been recovered
from classical male-specific lethal genetic screens. In addition to
direct regulators of MSL complex recruitment, it is possible that
transcriptional regulators identified from our screening approach
could function indirectly to regulate transcription of MSL complex
components themselves. Therefore, we used chromatin immuno-
precipitation and existing modEncode data to demonstrate that
two factors, the NSL complex and CG1832, are likely to have
local roles in MSL complex recruitment to CES. Moreover,
CG1832 is a strong candidate to recruit MSL complex directly to
CES due to its strong enrichment at MRE sequences.
Interestingly, we identified a previously unstudied function of the
highly-conserved NSL complex at CES loci. NSL and MSL
complex share the MOF histone acetyltransferase as their catalytic
component [13][36] and there are conserved MOF protein-protein
interaction interfaces between MSL1 and NSL1 [25]. Therefore, it
is possible that MSL complex and NSL complex would compete for
the MOF subunit, suggesting that NSL complex would antagonize
MSL complex. However, we instead found that NSL complex
facilitates MSL complex recruitment to CES (Figure 3). Therefore,
it is possible that MOF may be recruited to MSL entry sites via NSL
complex components such as MBD-R2 or RCD-5 that are known
to be involved in MOF recruitment to 59 ends of active genes
[37][36]. Subsequently, MOF could be transferred to newly
assembling MSL complexes at chromatin entry sites as previously
suggested [25]. Alternatively, since functional CES are enriched in
the vicinity of active genes [38], this could indicate a role for NSL-
dependent active gene expression in CES function.
Many additional activators were identified from our RNAi
screening approach including all components of the PAF
transcription complex that associates with RNAP II across gene
bodies to promote transcription elongation and polyadenylation
[26][16]. However, RNAi treatment targeting the PAF complex
did not alter MSL complex recruitment to entry sites or MSL
target genes (Figure 3A). There are several possible mechanisms by
which PAF complex could regulate our MSL-dependent reporter
gene. The PAF complex has been implicated in facilitating H2B
ubquitylation catalyzed by the S. cerevisiae SAGA complex
component Ubp8 [27][28]. H2B was also identified as an activator
in our screen potentially implicating H2B ubiquitylation in
facilitating MSL-dependent activity of the reporter (Table S1).
Moreover, recent work has identified a new activity for the MSL2
protein as an E3 ligase that targets H2B for ubiquitylation [29].
Therefore, it is possible that the PAF complex facilitates the H2B
ubiquitin ligase activity of MSL2. Alternatively, PAF has been
implicated in regulating H3K36me3 [39] suggesting that it could
also mediate MSL complex activity by modulating deposition of
this known regulator of MSL complex recruitment to active genes.
In addition to identifying activators of MSL-dependent reporter
activity, we identified several repressors including NURF301, a
was used instead of the MSL2 antibody. In addition to the normalization as described for (A), H4K16ac IPs were normalized to histone H3 occupancy
as determined by H3 ChIP. Due to significant changes in histone H3 occupancy upon paf1 RNAi treatment, these data were not included.
doi:10.1371/journal.pgen.1002830.g003
Factors Targeting Drosophila Dosage Compensation
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[24]. In this way, we validated that additional candidates have
potential to directly function in repressing MSL complex
recruitment or activity. Other repressors of known function
include the Sfmbt protein that recruits the Polycomb repressor
complex and the large TRRAP protein that mediates interactions
between gene specific regulators and large transcription complexes
[40]. It is possible that these proteins and other potential repressors
directly antagonize MSL complex function or alter the chromatin
environment around CES to reduce transcriptional activation.
Our most exciting new candidate is CG1832, a previously
unstudied zinc-finger protein that is strongly and precisely
Figure 4. NSL complex and CG1832 enrichment at CES loci. A) Heatmaps show the average enrichment of the Chromator/Chriz and MBD-R2
components of the NSL complex surrounding MRE sequences as assayed by ChIP-chip in SL2 cells (two replicates each; data available from http://
www.modENCODE.org). The darker red color indicates greater occupancy, as measured in the log2 (ChIP/input) scale. Heatmaps are shown for sets of
150 sites containing MREs that are defined as follows: MREs in chromatin entry sites (column 1); best MREs on the X chromosome or autosome 2L
(MRE motifs closest to the consensus, but not utilized, columns 2 and 4); randomly chosen MREs on the X or autosome 2L (columns 3 and 5). B)
Heatmaps show the enrichment of CG1832 surrounding MREs from ChIP-seq data in SL2 cells. Enrichment of CG1832 is shown surrounding the same
MREs that were examined in 4A. The log2 (ChIP/input) scale is used for binned read count; the enrichment difference is enhanced in the ChIP-seq
data owing to its greater dynamic range. C) Profiles of genome-wide localization data are shown for CG1832 (red), MBD-R2 (blue), and Chromator
(green), in a 30 Kb region including the roX2 locus.
doi:10.1371/journal.pgen.1002830.g004
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complex recruitment to these sites. This protein has seven zinc-
fingers at its C-terminus that could potentially bind DNA and a
glutamine-rich N-terminus that may interact with MSL complex.
Therefore, future analyses will focus on the exciting possibility that
CG1832 functions as a previously unknown link between MSL
complex and MRE sequences.
In summary, our novel screening approach identified two
regulators that facilitate MSL complex recruitment at CES: NSL
complex and CG1832. Furthermore, our genetic screen provides
an extensive dataset of additional candidate genes that may
facilitate MSL targeting and function. We expect that future
genetic, genomic, and biochemical approaches will define new
mechanisms by which many of these candidate genes modulate
coordinate gene regulation.
Methods
Genome-wide RNAi screen
A genome-wide RNAi screen was performed in duplicate using
the version 2 RNAi libraries generated by the Drosophila RNAi
Screening Center (www.flyrnai.org) [41]. Transient transfection of
MSL-dependent and independent luciferase reporter plasmids was
conducted as described previously [3]. For screening, all volumes
of plasmids and luciferase reagents were reduced by 4-fold to
accommodate a 384-well format from the original 96-well format.
As controls, GFP dsRNA was added to two wells and MSL2
dsRNA was added to two additional wells on every screening
plate. GFP and MSL2 dsRNA was prepared as described
previously [42]. All RNAi treatments were conducted for 5 days.
Identification of candidate regulators of MSL complex
targeting from RNAi screening data
First, the ratio of the Firefly luciferase to the Renilla luciferase
activity was computed for each well in each of the 124 screening
plates. Second, the Firefly/Renilla activity ratios for the GFP
dsRNA wells and the MSL2 dsRNA wells were compared to
assure that at least a 5-fold dynamic range was present for each
plate. All plates fulfilled these criteria. Third, we calculated the
median Firefly/Renilla ratio for each plate and its standard
deviation. Our criterion for identifying a well as a positive
screening hit was that its Firefly luciferase/Renilla luciferase ratio
is more that two standard deviations above or below the plate
median for both replicate plates. Most 384-well plates had 2–5
screening hits. To eliminate screening hits that cause non-specific
cell lethality or low transfection efficiency, we did not consider
wells with Renilla luciferase values that were more than three-fold
below the plate median. Secondary screens using validation
dsRNAs and additional plasmids described in [3] were performed
using the same protocol and analysis approach. All dsRNA
amplicons are identified in Table S1 by their DRSC number.
mRNA analysis and Western blotting
mRNA analysis and qRT-PCR was performed after the
following RNAi treatments: 1) DRSC03718 to target CG1832;
2) DRSC15625 to target NSL1 (CG4699); and 3) DRSC27502 to
target PAF1 (atms). All RNAi treatments were conducted for 5 days
in SL2 cells as previously described [42]. An additional CG1832
RNAi construct (DRSC 29935) was also tested with similar results
(data not shown).
Western blotting was conducted as previously described using
standard protocols [42]. We generated the rabbit polyclonal
CG1832 antibody against part of the glutamine-rich domain of the
protein (amino acids: #22-121) that was determined to be unique
in the Drosophila genome. For Western blotting, the CG1832
antibody was used at a 1:1000 dilution, the tubulin antibody
(Sigma) was used at a 1:10,000 dilution, and the histone H3
antibody (Abcam) was used at a 1:1000 dilution.
Chromatin immunoprecipitation
Chromatin immunoprecipitation from SL2 cells was conducted
as described previously [42] using antibodies targeting the MSL2
protein, H4K16ac (Millipore), H3 (Abcam), and CG1832 (SDI)
proteins. RNAi treatments were performed using the following
DRSC RNAi constructs (www.flyrnai.org): 1) DRSC03718 to
target CG1832; 2) DRSC15625 to target NSL1 (CG4699); and 3)
DRSC27502 to target PAF1 (atms). To assure reproducibility, large
scale RNAi experiments were performed in which 225 ug of each
dsRNA was added to a T225 flask containing 45 mls of SL2 cells.
An additional CG1832 RNAi construct (DRSC 29935) was also
tested with similar results (data not shown).
Three independent chromatin preparations were performed for
each experiment and qPCR was performed on input and IP
samples using primers that are specific for MSL target genes and
CES loci. Primer sequences were previously described [42].
Standard deviations among the three replicates were calculated
after normalization to a sample that was treated with the GFP
dsRNA construct as a control within each chromatin preparation.
mRNA extraction followed by qRT-PCR was performed in
parallel with each ChIP experiment to assure that the RNAi
treatments were effective.
Preparation of ChIP-seq libraries
Duplicate ChIP-seq libraries from independent chromatin
preparations were generated using a protocol adapted from the
Illumina ChIP-seq sample preparation guide as follows (www.
illumina.com). To obtain sufficient starting material, three IPs
were pooled and concentrated using Qiagen MinElute columns
such that 15 ng of starting material were obtained prior to library
preparation. Libraries from matching input samples were also
prepared for each chromatin preparation. Each enzyme reaction
was followed by purification using AMPure XP Beads (Agilent).
The fragmented DNA was 39 end repaired and 59 phosphorylated
using End-it Kit (Epicentre). A 39 adenosine was added using
Klenow Fragment (39R59 exo) (NEB). The annealed adapters
were ligated in a 1:50 dilution of the 10 mM stock using T4 DNA
Ligase Quick Ligase Kit (Enzymatics). The libraries were PCR
amplified using Phusion high fidelity polymerase (NEB) for 15
cycles. The libraries were then size selected on a 2% agarose gel
using the E-Gel system (Invitrogen) selecting a range from 200 bp
to 500 bp followed by concentration on a MinElute Column
(Qiagen). Sequencing was performed on the Illumina GaIIx
platform.
Analysis of ChIP-seq data
Reads were aligned to the dm3 assembly of the D. melanogaster
genome using the Bowtie aligner [43]. A summary of the
sequencing statistics is provided below:
Replicate #1 input: 29495696 raw reads, 17591247 aligned
reads (59.6%)
Replicate #1 CG1832 IP: 27820142 raw reads, 19210177
aligned reads (69.1%)
Replicate #2 input: 22498098 raw reads, 13510882 aligned
reads (60.1%)
Replicate #2 CG1832 IP: 28231400 raw reads, 15194724
aligned reads (53.8%)
Pearson R value for CG1832 ChIP-seq replicates, 1 kb bins:
0.95
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not align uniquely were discarded. Peaks were called in each
ChIP-seq sample using the SPP software package with an FDR
threshold of 0.05 [44]. For comparisons with MSL complex ChIP-
seq data, MSL complex ChIP-seq data [3] were realigned with
Bowtie and peaks were called with SPP in the same manner as the
CG1832 ChIP-seq samples, for more direct comparison. The
locations of CES loci and MRE sequences were previously
reported [3]. Data will be available at NCBI GEO Short Read
Archive (SRA) upon publication.
Generation of heatmaps
The average enrichment profiles of proteins around the MREs
(+/25 kb) are shown in Figure 4. The five columns in the heatmap
arethefollowing:‘MREinCES’consistsofexperimentallyobtained
140MREs (located within137CES) described in[3];‘Best MREon
X’ and ‘Best MRE on 2L’ consist of 150 MREs that have the best
consensus motif match on the X or 2L, respectively; and ‘Random
MRE on X’ and ‘Random MRE on 2L’ consist of 150 MREs
randomly chosen from the X or 2L, respectively. More details can
be found in Alekseyenko et al, 2012 (submitted).
modENCODE ChIP-chip data processing
ChIP-chip data using Genomic DNA Tiling Arrays v2.0
(Affymetrix) are publicly accessible online through the modEN-
CODE project (www.modencode.org). Data analysis was per-
formed in R statistical programming environment (http://www.r-
project.org). For the visualization of the heatmap (e.g., Figure 4),
the +/25 kb region surrounding each MRE was separated into
non-overlapping bins of 200 bp. The smoothed probe value within
each bin is averaged to obtain the enrichment value for that bin.
Heatmaps were generated using the same classes of MRE
containing loci as described above for the CG1832 ChIP-seq data.
Supporting Information
Figure S1 mRNA levels of MSL complex components and
candidates after CG1832, Nsl1, and Paf1 RNAi treatments. A)
qRT-PCR was used to assay the expression levels of all MSL
complex components present in SL2 cells. roX2 levels are
decreased likely because targeting of MSL complex to the roX2
CES locus is altered by the RNAi treatments as expected.
Expression levels of other MSL complex components are
unchanged. All data were normalized to the control RNAi
treatment and are the average of two replicates. B) Effective RNAi
treatments were validated by qRT-PCR and the results shown are
the average of two replicates.
(PDF)
Figure S2 Western blots for CG1832 RNAi treatment and
antibody validation. A) Westerns on whole cell and nuclear
extracts indicate that CG1832 is a nuclear protein and the
CG1832 RNAi treatment reduces CG1832 protein levels. The
arrow indicates the location of the CG1832 protein (60 kDa) and
tubulin was used as a loading control. B) Nuclear extraction was
performed on protein samples from SL2 (male) and Kc (female)
cells followed by Western blotting. The histone H3 antibody was
used as a loading control. Levels of CG1832 are similar in males
and females.
(PDF)
Figure S3 Validation of CG1832 antibody by ChIP at CES loci.
qPCR was performed on CG1832 ChIP samples before and after
CG1832 RNAi treatment. Three independent CES loci were
assayed and CG1832 RNAi strongly reduced the levels of CG1832
protein on chromatin at all three loci. An average of two
independent experiments is shown.
(PDF)
Figure S4 Immunostaining of polytene chromosomes. Polytene
staining using the CG1832 antibody (red) in male (A) and female
(B) larvae. Co-staining was performed with an anti-MSL3
antibody (green). Co-localization of the two proteins is shown in
yellow.
(PDF)
Table S1 Initial candidates identified from a genome-wide
RNAi screen to identify novel regulators of dosage compensation.
(XLSX)
Table S2 Final candidates identified from a genome-wide RNAi
screen. Candidates are color-coded and divided into functional
categories described at the bottom of the table.
(PDF)
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